Discover
KRYS
Krystal Biotech, Inc.
371.58
2 x 364.65
1 x 372.44
bid
ask
-
0.09
0.02%
2 @ 04:01 AM
379.97 +8.39 (2.26%)
| Ytd | 50.72% | |
| 1y | 167.30% |
363.27
day range
377.31
130.50
52 week range
382.54
| Open | 370.57 | Prev Close | 371.67 | Low | 363.27 | High | 377.31 | Mkt Cap | 10.95B |
| Vol | 296.69K | Avg Vol | 312.59K | EPS | 7.47 | P/E | 49.74 | Forward P/E | 36.88 |
| Beta | 0.53 | Short Ratio | 12.47 | Inst. Own | 99.40% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-03 | 50-d Avg | 308.96 | 200-d Avg | 252.80 | 1yr Est | 349.78 |
| Income Statement | |||
| Total Revenue | 116.36M | ||
| Revenues (USD) | 116.36M | ||
| Cost of Revenue | 6.32M | ||
| Gross Profit | 110.03M | ||
| Operating Expenses | 56.35M | ||
| Research and Development Expense | 15.33M | ||
| Selling, General and Administrative Expense | 41.01M | ||
| Operating Income | 53.69M | ||
| Income Tax Expense | 5.51M | ||
| Net Income | 55.93M | ||
| Net Income Common Stock | 55.93M | ||
| Net Income Common Stock (USD) | 55.93M | ||
| Consolidated Income | 55.93M | ||
| Earnings per Basic Share | 1.91 | ||
| Earnings per Basic Share (USD) | 1.91 | ||
| Earnings per Diluted Share | 1.83 | ||
| Earning Before Interest & Taxes (EBIT) | 61.44M | ||
| Earning Before Interest & Taxes (USD) | 61.44M | ||
| Weighted Average Shares | 29.29M | ||
| Weighted Average Shares Diluted | 30.51M | ||
| Balance Sheet | |||
| Cash and Equivalents | 501.31M | ||
| Cash and Equivalents (USD) | 501.31M | ||
| Investments | 515.58M | ||
| Investments Current | 322.09M | ||
| Investments Non-Current | 193.49M | ||
| Trade and Non-Trade Receivables | 127.02M | ||
| Current Assets | 1.02B | ||
| Property, Plant & Equipment Net | 160.62M | ||
| Total Assets | 1.40B | ||
| Debt Current | 1.80M | ||
| Total Debt | 9.11M | ||
| Current Liabilities | 107.80M | ||
| Debt Non-Current | 7.31M | ||
| Total Liabilities | 120.24M | ||
| Accumulated Retained Earnings (Deficit) | 80.10M | ||
| Accumulated Other Comprehensive Income | -1.62M | ||
| Shareholders Equity | 1.28B | ||
| Shareholders Equity (USD) | 1.28B | ||
| Assets Non-Current | 377.23M | ||
| Total Debt (USD) | 9.11M | ||
| Inventory | 42.65M | ||
| Liabilities Non-Current | 12.44M | ||
| Trade and Non-Trade Payables | 4.09M | ||
| Tax Assets | 33.47M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.73M | ||
| Net Cash Flow from Financing | -10.46M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 5.01M | ||
| Capital Expenditure | -7.15M | ||
| Issuance (Purchase) of Equity Shares | 6.50M | ||
| Net Cash Flow from Investing | -63.58M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -56.43M | ||
| Net Cash Flow from Operations | 80.38M | ||
| Effect of Exchange Rate Changes on Cash | -1.33M | ||
| Share Based Compensation | 13.61M | ||